Endostart
Company

Last deal

$10M
Local Amount - EUR 8.2M

Amount

Series B

Stage

07.06.2021

Date

2

all rounds

$11.1M

Total amount

General

About Company
Endostart has developed a proprietary Magnetic Balloon Anchoring Technology for guiding and navigating colonoscopy procedures.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2018

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Founded in 2018, Endostart is a startup focused on developing and manufacturing advanced medical devices for gastrointestinal endoscopy. Their innovative technologies, including a magnetic balloon guide, ferrofluid syringe, and a multi-use magnetic handpiece, help reduce wall stress during colonoscopy procedures, minimizing the need for general anesthesia. Collaborating with research centers, high-tech suppliers, and CNR, they have enhanced endoscope performance to meet quality standards. Achieving CE marks for their first and second-generation Endorail Systems in 2019 and 2022 respectively, Endostart also adheres to ISO 13485 for comprehensive quality management. With support from private and institutional investors and a skilled team, Endostart is poised to revolutionize gastrointestinal endoscopy.